These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 26186939)
1. The biology of pediatric acute megakaryoblastic leukemia. Gruber TA; Downing JR Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome. Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia]. Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387 [TBL] [Abstract][Full Text] [Related]
4. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene. Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503 [TBL] [Abstract][Full Text] [Related]
5. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737 [TBL] [Abstract][Full Text] [Related]
6. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children. Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368 [TBL] [Abstract][Full Text] [Related]
7. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies. Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921 [TBL] [Abstract][Full Text] [Related]
9. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report. Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081 [TBL] [Abstract][Full Text] [Related]
10. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651 [TBL] [Abstract][Full Text] [Related]
11. ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia. Thirant C; Ignacimouttou C; Lopez CK; Diop M; Le Mouël L; Thiollier C; Siret A; Dessen P; Aid Z; Rivière J; Rameau P; Lefebvre C; Khaled M; Leverger G; Ballerini P; Petit A; Raslova H; Carmichael CL; Kile BT; Soler E; Crispino JD; Wichmann C; Pflumio F; Schwaller J; Vainchenker W; Lobry C; Droin N; Bernard OA; Malinge S; Mercher T Cancer Cell; 2017 Mar; 31(3):452-465. PubMed ID: 28292442 [TBL] [Abstract][Full Text] [Related]
12. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433 [TBL] [Abstract][Full Text] [Related]
13. Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children. Ono R; Hasegawa D; Hirabayashi S; Kamiya T; Yoshida K; Yonekawa S; Ogawa C; Hosoya R; Toki T; Terui K; Ito E; Manabe A Eur J Pediatr; 2015 Apr; 174(4):525-31. PubMed ID: 25266042 [TBL] [Abstract][Full Text] [Related]
14. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene. Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896 [TBL] [Abstract][Full Text] [Related]
15. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL. Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450 [TBL] [Abstract][Full Text] [Related]